Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABMT OTCMKTS:ADMT OTCMKTS:AKSY OTCMKTS:PFND On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00$0.00▼$0.00N/A1.561,100 shsN/AADMTADM Tronics Unlimited$0.05-1.1%$0.06$0.03▼$0.11$3.71M-0.066,307 shs9,100 shsAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/APFNDPathfinder Cell Therapy$0.00$0.00▼$0.00N/AN/AN/AN/AA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%-75.00%-75.00%-83.33%ADMTADM Tronics Unlimited-1.08%-6.79%+0.73%-13.68%-16.31%AKSYAksys0.00%0.00%0.00%0.00%0.00%PFNDPathfinder Cell Therapy0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AN/AN/AN/APFNDPathfinder Cell TherapyN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMTAdvanced Biomedical Technologies 0.00N/AN/AN/AADMTADM Tronics Unlimited 0.00N/AN/AN/AAKSYAksys 0.00N/AN/AN/APFNDPathfinder Cell Therapy 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMTAdvanced Biomedical Technologies$270KN/AN/AN/AN/AN/AADMTADM Tronics Unlimited$3.20M1.16N/AN/AN/A∞AKSYAksysN/AN/AN/AN/AN/AN/APFNDPathfinder Cell TherapyN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMTAdvanced Biomedical Technologies-$510KN/A0.00N/AN/AN/AN/AN/AN/AADMTADM Tronics Unlimited-$880KN/A0.00∞N/A-13.47%-49.27%-18.74%8/18/2025 (Estimated)AKSYAksysN/AN/A0.00N/AN/AN/AN/AN/AN/APFNDPathfinder Cell TherapyN/AN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AADMTADM Tronics UnlimitedN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/APFNDPathfinder Cell TherapyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioABMTAdvanced Biomedical TechnologiesN/AN/AN/AADMTADM Tronics UnlimitedN/A1.210.78AKSYAksysN/AN/AN/APFNDPathfinder Cell TherapyN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMTAdvanced Biomedical TechnologiesN/AADMTADM Tronics UnlimitedN/AAKSYAksysN/APFNDPathfinder Cell TherapyN/AInsider OwnershipCompanyInsider OwnershipABMTAdvanced Biomedical Technologies34.11%ADMTADM Tronics Unlimited73.00%AKSYAksys3.80%PFNDPathfinder Cell Therapy15.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMTAdvanced Biomedical Technologies20N/AN/ANot OptionableADMTADM Tronics Unlimited2367.59 million18.25 millionNot OptionableAKSYAksys87N/AN/ANot OptionablePFNDPathfinder Cell Therapy1N/AN/ANot OptionablePFND, ADMT, ABMT, and AKSY HeadlinesRecent News About These Companiest-cell therapyOctober 31, 2023 | hackaday.comHGrail Pathfinder Publication Offers Glimpse of Multi-Cancer Clinical Screening ImpactsOctober 13, 2023 | precisionmedicineonline.comPPathfinder Cell Therapy, Inc. (PFND)October 10, 2023 | finance.yahoo.comWhat's the Treatment for Nonmelanoma Skin Cancer?October 7, 2023 | webmd.comWDendritic Cell Therapy for Type 1 Diabetes SuppressionOctober 6, 2023 | medscape.comMFinal Results From PATHFINDER Study of GRAIL's Multi-Cancer Early Detection Blood Test Published in The LancetOctober 5, 2023 | benzinga.comCell Therapy Repairs Cornea Damage With Patient’s Own Stem CellsSeptember 10, 2023 | technologynetworks.comTStem cell therapy for type 1 diabetes mellitusAugust 22, 2023 | nature.comNCell Replacement Therapy for Parkinson's DiseaseAugust 20, 2023 | medscape.comMGene and Cell TherapyAugust 17, 2023 | technologynetworks.comTThird- and Further-line Therapy in Advanced Non-small-cell Lung Cancer PatientsAugust 2, 2023 | medscape.comMTail spin: Study reveals new way to reduce friendly fire in cell therapyAugust 1, 2023 | medicalxpress.comMUB, partner awarded $3 million NIH grant to study immune cell therapy for tumorsJuly 19, 2023 | buffalo.eduBStem Cell Therapy News, Research and Latest UpdatesJuly 10, 2023 | medindia.netMYour First Therapy SessionJune 28, 2023 | psychologytoday.comPTherapy for Teens: What to ExpectJune 25, 2023 | webmd.comWTopical Imiquimod Therapy for Cutaneous T-Cell LymphomaJune 13, 2023 | medscape.comMTherapy: Does It Ever End?June 12, 2023 | webmd.comWNew multiple myeloma cell therapy yields dramatic resultsJune 11, 2023 | israel21c.orgIB-Cell Therapy for Multiple Sclerosis: Be InformedJune 9, 2023 | webmd.comWMedia Sentiment Over TimePFND, ADMT, ABMT, and AKSY Company DescriptionsAdvanced Biomedical Technologies OTCMKTS:ABMTAdvanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.ADM Tronics Unlimited OTCMKTS:ADMT$0.05 0.00 (-1.08%) As of 07/17/2025 09:49 AM EasternADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.Aksys OTCMKTS:AKSYAksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.Pathfinder Cell Therapy OTCMKTS:PFNDPathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap How Goldman Sachs Earnings Help You Strategize Your Portfolio Is Amazon Really the Best Forever Stock for Your Portfolio? Full Steam Ahead: The Bullish Case for Carnival Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
